Exploratory study to assess the pharmacokinetic interaction of doxepin with adrenaline after a concomitant co-administration using the Anapen® device and to compare the adrenaline comparative bioavailability with Anapen®500 commercial form in healthy normal weight male subjects
P23-01
Phase 1 other active
Quick answer
Exploratory study to assess the pharmacokinetic interaction of doxepin with adrenaline after a concomitant co-administration using the Anapen® device and to compare the adrenaline comparative bioavailability with Anapen®500 commercial form in healthy normal weight male subjects for Anaphylaxis is a Phase 1 program (other) at Bioprojet Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bioprojet Pharma
- Indication
- Anaphylaxis
- Phase
- Phase 1
- Modality
- other
- Status
- active